The FDA has proposed ending the use of a common ingredient found in many cold and allergy medicines — and some pharmacies ...
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drug. Biogen said Thursday that the drug, known in the U.S. as Leqembi, ...
The Saskatchewan legislature is to reconvene on Nov. 25, with the governing Saskatchewan Party's seat count severely reduced ...
The company is establishing a North Carolina factory for cold medicine as postpandemic pharma demand has grown more ...
The FDA wants these cold medicines off the shelves. Should Canada follow? Still trying to see Taylor Swift in Toronto? Last-minute tickets priced as high as $33K The department had a biologist from ...
Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, has released compelling new insights from a recent Androgen Deficiency in Aging ...
Dr. Justin Skrzynski or Corewell Health will help us sort it out. When you have a cold and go into the drug store, your ...
The Food and Drug Administration announced Wednesday its intention to remove oral phenylephrine, a common ingredient in ...
A New York federal judge on Tuesday dismissed about 100 lawsuits that claimed Procter & Gamble , Haleon and other companies ...
Bessem Oben, the manager and COO of GoldStar Pharmacy in College Station, explained to KBTX the active ingredient, ...
The Food and Drug Administration (FDA) is proposing the removal from the market of a common ingredient found in most oral ...
Turmeric is a natural herb that may affect how well other medications and supplements work. This includes cancer medications ...